IMT Protocol for COPD Patients (IMTCO) study design uses POWERbreathe KH1

Respiratory medicine:

Inspiratory muscle training protocol for patients with chronic obstructive pulmonary disease (IMTCO study): a multicentre randomised controlled trial

Noppawan Charususin, Rik Gosselink, Marc Decramer, et al
Published 5 August 2013

The latest paper on the Inspiratory Muscle Training Protocol for Patients with COPD (IMTCO) study design has just been published in Respiratory Medicine on BMJ Open. This study used the POWERbreathe KH1 for home-based IMT. It is suggested that the results of the study could be incorporated into evidence-based treatment recommendations for clinical practice. ClinicalTrials.gov NCT01397396.

Aims of the study:

“This study will examine the effects of adding a well-controlled, high-intensity IMT programme to a 3-month general exercise training programme, using a large, multicentre, randomised controlled design, in patients with COPD and inspiratory muscle weakness. Outcomes will be exercise capacity (primary outcome), inspiratory muscle function, health-related quality of life (HRQL) and participation in daily physical activity.”

Read the full Open Access article online.

Leave a Comment

Sorry, you must be logged in to post a comment.